Weight-loss drugs from GlaxoSmithKline PLC and Roche Holding AG will carry new warnings about rare reports of liver injury, U.S. health officials said on Wednesday. The Food and Drug Administration ...

XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic benefits through a unique fat-blocking mechanism. However, its high incidence ...

Auckland, March 10 2005 – Weight loss medication Xenical® (orlistat) is now available direct from a pharmacist for the first time in New Zealand. Xenical has been re-classified to a pharmacist only ...

The FDA has notified healthcare professionals and consumers that it is reviewing new safety information regarding reports of liver-related adverse events in patients taking orlistat, which is marketed ...

Surveyed PCPs Who Selected Amylin/Eli Lilly’s Byetta or Novo Nordisk’s Victoza as Having the Best Efficacy Were Most Satisfied With the Effect of These Agents on Diabetes-Related Risk Factors, ...

So Paulo, Brazil - Patients taking 120 mg of orlistat (Xenical® - Roche) and following a program of diet and exercise show greater long-term weight loss and a reduced risk of developing type 2 ...